Lisa Polin

4.0k total citations
102 papers, 3.0k citations indexed

About

Lisa Polin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Polin has authored 102 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 30 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Polin's work include Cancer therapeutics and mechanisms (14 papers), Folate and B Vitamins Research (11 papers) and Histone Deacetylase Inhibitors Research (10 papers). Lisa Polin is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Folate and B Vitamins Research (11 papers) and Histone Deacetylase Inhibitors Research (10 papers). Lisa Polin collaborates with scholars based in United States, China and Saudi Arabia. Lisa Polin's co-authors include Kathryn White, Juiwanna Kushner, Thomas H. Corbett, Jerome P. Horwitz, Eduardo Palomino, Stuart Hazeldine, Larry H. Matherly, Zhanjun Hou, Aleem Gangjee and Arun K. Rishi and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Blood.

In The Last Decade

Lisa Polin

101 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lisa Polin	1.6k	583	563	363	249	102	3.0k
A. Chaikuad	2.9k 1.8×	760 1.3×	784 1.4×	231 0.6×	247 1.0×	123	4.4k
K. Huber	1.9k 1.2×	518 0.9×	665 1.2×	224 0.6×	74 0.3×	60	3.0k
Chuan Shih	1.4k 0.9×	790 1.4×	687 1.2×	175 0.5×	157 0.6×	81	2.9k
Uwe Rix	2.6k 1.7×	841 1.4×	1.0k 1.9×	269 0.7×	415 1.7×	89	4.9k
Jack C. Yalowich	2.9k 1.9×	790 1.4×	1.3k 2.3×	281 0.8×	107 0.4×	114	4.5k
Mark A. Ator	1.8k 1.1×	602 1.0×	772 1.4×	155 0.4×	92 0.4×	91	3.1k
Hirofumi Nakano	1.6k 1.0×	434 0.7×	637 1.1×	242 0.7×	42 0.2×	140	3.1k
Rosanna Supino	3.0k 1.9×	593 1.0×	1.7k 3.1×	803 2.2×	210 0.8×	109	4.9k
Steven A. Akman	2.5k 1.6×	229 0.4×	827 1.5×	593 1.6×	71 0.3×	108	4.3k
Brian Dymock	1.8k 1.1×	553 0.9×	513 0.9×	73 0.2×	96 0.4×	78	2.9k

Countries citing papers authored by Lisa Polin

Since Specialization

Citations

This map shows the geographic impact of Lisa Polin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Polin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Polin more than expected).

Fields of papers citing papers by Lisa Polin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Polin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Polin. The network helps show where Lisa Polin may publish in the future.

Co-authorship network of co-authors of Lisa Polin

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Polin. A scholar is included among the top collaborators of Lisa Polin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Polin. Lisa Polin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carter, Jenna L., Yongwei Su, Jianlei Zhao, et al.. (2025). ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress. Journal of Experimental & Clinical Cancer Research. 44(1). 10–10.

Wallace-Povirk, Adrianne, Xun Bao, Jennifer Wong-Roushar, et al.. (2024). Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 23(6). 809–822. 8 indexed citations

Uddin, Md. Hafiz, Amro Aboukameel, Husain Yar Khan, et al.. (2024). Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia. Blood. 144(Supplement 1). 2768–2768. 2 indexed citations

Heyza, Joshua, Christopher K. Yunker, Lisa Polin, et al.. (2023). ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. NAR Cancer. 5(1). zcac045–zcac045. 4 indexed citations

Parajuli, Prahlad, Rayna Rosati, Hirva Mamdani, et al.. (2022). Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes. Cancer Immunology Immunotherapy. 72(5). 1273–1284. 7 indexed citations

Ma, Jun, Tristan Knight, Yongwei Su, et al.. (2021). The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer Journal. 11(6). 111–111. 27 indexed citations

Liu, Fangbing, Hasini A. Kalpage, Holly Edwards, et al.. (2020). Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation. Cancers. 12(9). 2400–2400. 29 indexed citations

Luedtke, Daniel A, Yongwei Su, Jun Ma, et al.. (2020). Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia. Signal Transduction and Targeted Therapy. 5(1). 17–17. 50 indexed citations

Chen, Hu, Mu Zhang, Lisa Polin, et al.. (2020). The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. Cell Death and Disease. 11(5). 328–328. 48 indexed citations

10.

Ma, Jun, Tristan Knight, Holly Edwards, et al.. (2019). Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia. Clinical Cancer Research. 25(22). 6815–6826. 117 indexed citations

11.

Rosati, Rayna, Lisa Polin, Charles Ducker, et al.. (2018). Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer. Clinical Cancer Research. 24(24). 6509–6522. 16 indexed citations

12.

Saadat, Nadia, Fangchao Liu, Brittany Haynes, et al.. (2018). Nano-delivery of RAD6 /Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy. Molecular Cancer Therapeutics. 17(12). 2586–2597. 15 indexed citations

13.

Rosati, Rayna, Yanfang Huang, Lisa Polin, et al.. (2018). Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Scientific Reports. 8(1). 16006–16006. 10 indexed citations

14.

Lawhorn‐Crews, Jawana M., Lisa Polin, Shirish M. Gadgeel, et al.. (2018). Using Radiolabeled 3′-Deoxy-3′-¹⁸F-Fluorothymidine with PET to Monitor the Effect of Dexamethasone on Non–Small Cell Lung Cancer. Journal of Nuclear Medicine. 59(10). 1544–1550. 9 indexed citations

15.

Hou, Zhanjun, Yang Si, Adrianne Wallace-Povirk, et al.. (2017). Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates. Molecular Cancer Therapeutics. 16(5). 819–830. 38 indexed citations

16.

Huang, Yanfang, et al.. (2016). Long-term treatment with dexamethasone induces senescence and progressive loss of proliferation potential in lung adenocarcinoma cells expressing high levels of the glucocorticoid receptor. Journal of Thoracic Oncology. 11(2). S36–S36. 1 indexed citations

17.

Yang, Huanjie, Ying Wang, Wenjuan Wu, et al.. (2013). Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo. PLoS ONE. 8(2). 1 indexed citations

18.

Cherian, Christina, Sita Kugel Desmoulin, Lei Wang, et al.. (2013). Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter. Cancer Chemotherapy and Pharmacology. 71(4). 999–1011. 20 indexed citations

19.

Risinger, April L., Evelyn M. Jackson, Lisa Polin, et al.. (2008). The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms. Cancer Research. 68(21). 8881–8888. 111 indexed citations

20.

Merisko‐Liversidge, Elaine, Pramod P. Sarpotdar, Joseph G. Bruno, et al.. (1996). Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs. Pharmaceutical Research. 13(2). 272–278. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact